论文部分内容阅读
目的:观察依达拉奉治疗急性脑梗死的疗效。方法:将急性脑梗死96例随机分为治疗组50例和对照组46例,对照组采用蕲蛇酶及阿司匹林治疗;治疗组在上述基础上,将依达拉奉30mg加入生理盐水100ml静脉滴注,每天2次,2周为一疗程。结果:治疗组神经功能损害程度评分显著下降,临床疗效显著高于对照组(P<0.05)。结论:依达拉奉治疗急性脑梗死疗效满意,可作为治疗急性脑梗死的药物使用。
Objective: To observe the therapeutic effect of edaravone on acute cerebral infarction. Methods: Ninety-six acute cerebral infarction patients were randomly divided into treatment group (n = 50) and control group (n = 46). Control group was treated with viper and aspirin. On the basis of the above, the treatment group received edaravone 30mg Note, 2 times a day, 2 weeks for a course of treatment. Results: The score of neurological impairment in treatment group decreased significantly, and the clinical effect was significantly higher than that in control group (P <0.05). Conclusion: Edaravone is effective in treating acute cerebral infarction and can be used as medicine for treating acute cerebral infarction.